Stream Link 1 PM: https://globalmeet.webcasts.com/starthere.jsp?ei=1677445&tp_key=cd9438d383
Stream Link 8 PM: https://globalmeet.webcasts.com/starthere.jsp?ei=1677449&tp_key=a20dc75416
This activity is part 3 of a 3-part webinar curriculum and includes a Powered by Patients™ video interview.
Program Description
Specialty pharmacists play a vital role in managing ophthalmic diseases and ensuring patients receive the most effective medications. With the growing number of treatment options for patients with retinal diseases, decision-making is more complex and requires careful consideration of benefits, risks, and patient goals. This webinar will review communication strategies that specialty pharmacists can employ to further contribute to patient care in age-related macular degeneration (AMD) and diabetic macular edema (DME). The expertise of specialty pharmacists in drug access is crucial for optimizing anti-vascular endothelial growth factor (anti-VEGF) therapy management. They can take important steps to account for patient preference for medications when incorporating new and emerging agents into treatment approaches for AMD and DME to improve real-world outcomes. The program will also explore the significant advantages of integrating pharmacists into ophthalmologic care, ultimately improving patient outcomes for AMD and DME. A Powered by Patients™ interview will be included within the presentation, featuring the perspective of an individual living with AMD/DME and their experience with accessing anti-VEGF therapies.
Target audience: Specialty pharmacists
Type of activity: Application
Release date: August 13, 2024
Expiration date: October 13, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Document communication strategies provided by specialty pharmacists that support appropriate, effective, and comprehensive anti-vascular endothelial growth factor therapy management
- Determine advantages to incorporating pharmacists into ophthalmologic care
Natalie M. Ryan, PharmD, BCPP, CSP, MS
Vice President, Specialty Pharmacy
Value Specialty Pharmacy
Duncansville, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-182-L01-P. The activity is available for CE credit through October 13, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Natalie M. Ryan, PharmD, BCPP, CSP, MS
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Adam C. Welch, PharmD, MBA, FAPhA; Kylie Ferrentino; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms